Zhe Sang

机构：Icahn School of Medicine at Mount Sinai · ORCID：0000-0002-1516-2796

发表论文 30 篇 · 总被引 1168 次 · h-index 12

代表论文

• Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses (2021 · Science Advances · 被引 171)
• Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes (2021 · Nature Communications · 被引 107)
• Nanobodies: Robust miniprotein binders in biomedicine (2023 · Advanced Drug Delivery Reviews · 被引 82)
• Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies (2021 · Cell Systems · 被引 67)
• Llamanade: An open-source computational pipeline for robust nanobody humanization (2021 · Structure · 被引 58)
• Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy (2024 · Cell · 被引 48)